Camc Health System
Clinical trials sponsored by Camc Health System, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Could a common cholesterol drug help slow liver failure? Results expected Mar 2027 (estimated)
- Radiologists take the lead: can deep sedation replace general anesthesia? Results expected Apr 2027 (estimated)
-
Could a common cholesterol drug help slow liver failure?
Disease control Recruiting nowThis pilot study tests whether adding the statin atorvastatin to a standard beta blocker can help people with decompensated cirrhosis, a severe form of liver disease. Fifty participants will receive either atorvastatin plus their usual beta blocker or a placebo plus beta blocker,…
Phase 2 • Sponsor: CAMC Health System • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Radiologists take the lead: can deep sedation replace general anesthesia?
Symptom relief Recruiting nowThis study tests whether interventional radiologists can safely give deep sedation using ketamine, fentanyl, and midazolam for procedures that normally require general anesthesia. Up to 40 adults will participate. The main goal is to see if the procedure can be completed without …
Phase 1/2 • Sponsor: CAMC Health System • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC